TABLE 1.
Construct | Mutation
|
Replicationc | |
---|---|---|---|
Nucleotide position(s) | Position(s)b in mutated core promoter sequence | ||
Mutants | |||
MT5/6 | 1768, 1770 | TAAAGGTTTATGTATT | 15 |
MT8 | 1764, 1766 | TAATGATCTTTGTATT | 1.5–2 |
MT9 | 1770 | TAAAGGTCTGTGTATT | No change |
MT10 | 1768, 1770 | TAAAGGTATGTGTATT | No change |
MT11 | 1768, 1770 | TAAAGGTGTATGTATT | No change |
MT12 | 1768 | TAAAGGTATTTGTATT | No change |
MT13 | 1768, 1770 | TAAAGGTATATGTATT | No change |
MT14 | 1772 | TAAAGGTCTTTATATT | No change |
WT adw | TAAAGGTCTTTGTATT | 1 |
Various mutations were introduced into the replication-competent construct adwR9 by oligonucleotide-directed mutagenesis. Four days after transfection of wild-type (WT) and mutant constructs into HuH-7 cells, viral replication was analyzed by Southern blotting of core particle-associated viral replicative intermediates as shown in Fig. 8A. The amount of viral replicative intermediates was quantified with a phosphor imager. Core promoter nucleotide positions are numbered according to reference 32 and MT8, represents mutations described in reference 34.
Underlined.
Shown as fold increase compared to replication of wild-type HBV adw (replicative intermediates of wild-type adw construct = 1).